KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $219,817 | -22.0% | 1,300 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $281,905 | +19.4% | 1,300 | 0.0% | 0.00% | – |
| Q1 2023 | $236,132 | -82.6% | 1,300 | -87.9% | 0.00% | -100.0% |
| Q2 2022 | $1,357,000 | -43.5% | 10,730 | -43.3% | 0.00% | -50.0% |
| Q1 2022 | $2,400,000 | -4.8% | 18,930 | -1.8% | 0.00% | 0.0% |
| Q4 2021 | $2,521,000 | +7.0% | 19,269 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,357,000 | +7.5% | 19,269 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $2,193,000 | -13.5% | 19,242 | -8.7% | 0.00% | 0.0% |
| Q1 2021 | $2,535,000 | -13.4% | 21,086 | -26.8% | 0.00% | -33.3% |
| Q4 2020 | $2,928,000 | +18.4% | 28,816 | -9.9% | 0.00% | 0.0% |
| Q3 2020 | $2,472,000 | -39.2% | 31,972 | -12.3% | 0.00% | -40.0% |
| Q2 2020 | $4,064,000 | +123.4% | 36,463 | +44.4% | 0.01% | +150.0% |
| Q1 2020 | $1,819,000 | – | 25,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
| Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
| First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
| Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
| MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
| PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
| Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
| Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
| Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
| CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |